Impact of Checkpoint Inhibitor Immunotherapy, Primarily Pembrolizumab, on Infection Risk in Patients With Advanced Lung Cancer: A Comparative Retrospective Cohort Study
Alexandre Malek(Louisiana State University Health Sciences Center Shreveport), Issam Raad(Missouri Department of Agriculture), Patrick Chaftari(The University of Texas MD Anderson Cancer Center), Melissa Khalil(The University of Texas MD Anderson Cancer Center), Ray Hachem(The University of Texas MD Anderson Cancer Center), George M. Viola(The University of Texas MD Anderson Cancer Center), Dimitrios P. Kontoyiannis(The University of Texas MD Anderson Cancer Center), Victor E. Mulanovich(The University of Texas MD Anderson Cancer Center), Anne Marie Chaftari(The University of Texas MD Anderson Cancer Center), Ying Jiang(The University of Texas MD Anderson Cancer Center), Johny Fares(The University of Texas MD Anderson Cancer Center), Frank V. Fossella(Ontario Institute for Cancer Research)
Cited by 15
Related Papers
Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter-Related Infection: 2009 Update by the Infectious Diseases Society of America
|Clinical Infectious Diseases|2009|3.6k
Epidemiology and Outcome of Zygomycosis: A Review of 929 Reported Cases
|Clinical Infectious Diseases|2005|3k
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
|Clinical Infectious Diseases|2016|2.8k
Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium
|Clinical Infectious Diseases|2019|2.8k
Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America
|Clinical Infectious Diseases|2008|2.7k